Pharmaceutical

Pharmanovia signs license agreement for Lindis Biotech’...

Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialis...

Wes Streeting says patients should view data sharing ‘t...

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragme...

KM Biologics’ mpox vaccine approved for emergency use b...

The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 ...

Tris Pharma receives ex-US approvals for ADHD treatments

Tris Pharma has received additional ex-US approvals for its ADHD treatments, Qui...

Veeva Commercial Summit: Increased investment in medica...

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scient...

Parkinson’s disease cases to reach 3.15 million in 7MM ...

Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in ...

EC marketing authorisation granted to Pfizer’s HYMPAVZI...

The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathw...

Leading sales enablement, prospecting and automation pr...

Discover leading sales enablement and marketing intelligence solutions tailored ...

UK life science startups have trouble “scaling up” says...

The UK Minister of State for Science praised the UK’s thriving startup scene at ...

Kura Oncology partners Kyowa Kirin to advance AML treat...

Kura has partnered Kyowa Kirin in a strategic global collaboration for developin...

AHA 2024: Plozasiran demonstrates promising Phase III r...

During AHA 2024, data were presented from the Phase III trial of plozasiran targ...

AHA 2024: lerodalcibep provides promising results in op...

At AHA 2024, clinical trial results were presented from the ongoing open-label e...

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

The EMA's CHMP has recommended approval of a combination therapy of BMS's Opdivo...

AHA 2024: Tirzepatide improves outcomes for major heart...

Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide a...

CHMP recommends AstraZeneca’s Tagrisso for EU approval ...

EMA's CHMP has recommended AstraZeneca's Tagrisso for approval in the European U...

AstraZeneca picks first Treg cell therapy from Quell Th...

AstraZeneca will advance preclinical and clinical development of the Type 1 Diab...